Faculty

Research

Systems

Infrastructure

Patient & Public Awareness

Working with Industry

Research Databases

About Us

News: Artificial pancreas to revolutionise the treatment of patients with Type 1 diabetes

Title

Artificial pancreas to revolutionise the treatment of patients with Type 1 diabetes 

News Title

Artificial pancreas to revolutionise the treatment of patients with Type 1 diabetes 

News Content

A new clinical trial is testing an ‘artificial pancreas’, with patients under the age of five, who are too young to recognise the warning signs of a drop in their blood. Using an off-the-shelf insulin pump and continuous glucose sensor, a computer algorithm controls their function in a closed-loop fashion, delivering the correct amount of insulin according to blood sugar levels. This has the potential to revolutionise the treatment of patients with Type 1 diabetes and significantly improve their quality of life. The glucose-responsive insulin delivery system has been trialled in adolescents, adults and pregnant women with Type 1 diabetes at the NIHR/ Wellcome Trust Cambridge Clinical Research Facility (CRF), and follow-on studies are on-going with these groups at home.

News Link

Cambridge University media release 

News Date

21/05/2013 

Expires

21/06/2013 

Date Created

 

Date Modified

 
Attachments
Created at 21/05/2013 17:11  by Leonilde Yahyaoui 
Last modified at 21/05/2013 17:11  by Leonilde Yahyaoui